HKUMed Unveils Broader Potential of Fatty Liver Medication in Liver Cancer Prevention and Treatment
A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved medication for metabolic dysfunction-associated fatty...
















